TCTMD - tctmd.com
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
Slides | tctmd.com
Apr 14, 2024 — TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
TCTMD Login - tctmd.com
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Injectable Semaglutide Shortage Forces Physicians to Pivot
Feb 5, 2024 — Shortages of injectable semaglutide (Novo Nordisk), sold under trade names Ozempic (for type 2 diabetes with or without established CVD) and Wegovy (for overweight or obesity), are forcing clinicians to look to alternatives when managing patients who …
Micra Leadless Pacemaker Performs Well Through 5 Years
Mar 6, 2024 — Photo Credit: Adapted from Brown K. TCT 564: A new perspective: intracardiac echocardiographic guidance for the implantation of a left atrial appendage occluder device (Watchman) with a leadless pacemaker (Micra).
When the Time Comes to Stop Oral Anticoagulation: Options and …
Sep 28, 2021 — Oral anticoagulants can prevent thrombotic events and save lives in patients with atrial fibrillation (AF) and other conditions, but they don’t in and of themselves make patients feel better.
TCT 2023 - TCTMD.com
Oct 23, 2023 — TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Cheaper Version of Tirzepatide for Weight Loss Now Available, …
Aug 28, 2024 — The manufacturer is selling single-dose vials of the drug via its online pharmacy at around $400 to $500 for a 4-week supply.
FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels
Dec 22, 2021 — The US Food and Drug Administration has approved inclisiran (Leqvio; Novartis), a small interfering RNA (siRNA) therapy, for lowering LDL cholesterol levels, the drugmaker announced today.
Which TAVR Device Is Best? Review Tackles Optimal Selection
Sep 9, 2020 — Although the majority of patients with symptomatic, severe aortic stenosis can be suitably treated with any of the commercially available transcatheter heart valves, a new review highlights several variables that might lead clinicians to choose one device over another.